The combination of ulinastatin and somatostatin reduces complication rates in acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials

Currently, there is no specific pharmaceutical agent for treating acute pancreatitis (AP). Somatostatin and its analogues have been used to prevent the autolysis of the pancreas in AP, however, their effectiveness has not been confirmed. This investigation aimed to examine the efficacy of ulinastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Horváth, István László, Bunduc, Stefania, Fehérvári, Péter, Váncsa, Szilárd, Nagy, Rita, Garmaa, Gantsetseg, Kleiner, Dénes, Hegyi, Péter, Erőss, Bálint, Csupor, Dezső
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606296/
https://www.ncbi.nlm.nih.gov/pubmed/36289288
http://dx.doi.org/10.1038/s41598-022-22341-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606296/
https://www.ncbi.nlm.nih.gov/pubmed/36289288
http://dx.doi.org/10.1038/s41598-022-22341-7

Ejemplares similares